Biotech

All Articles

Zephyrm seeks Hong Kong IPO to cash period 3 cell treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO...

Frazier Life Sciences collects $630M for little, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an even more $630 thousand for its fund concent...

GigaGen achieves approximately $135M BARDA dollars to hammer botox

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its specialist t...

GPCR agency Septerna declare IPO on toughness of preclinical records

.Septerna is about to figure out how a biotech without "any type of relevant scientific information"...

Kurma finalizes initially $154M loot for most significant biotech fund as yet

.International VC firm Kurma Allies has actually revealed its own most current biotech fund, along w...

Prothena advertises one officer while one more places-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Editas capitalize Vertex Cas9 licensing rights for $57M

.Versus the backdrop of a Cas9 patent war that declines to perish, Editas Medication is moneying in ...

Ultragenyx changes genetics therapy application to dial up efficiency

.A minority of individuals taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have actua...

Biopharma unemployment fee stabilizes in Q3: Ferocious Biotech study

.As summer season heat turns to cool winds, hopes that this year would carry common sector relief ha...

J &amp J goes down phase 2 dengue prospect in newest shift from vaccinations

.Johnson &amp Johnson's deprioritization of its own contagious ailment pipeline has actually asserte...